HIF-1, NF-κB, IL-17, EGFR, MAPK, endocrine resistance, tyrosine kinase resistance, platinum drug resistance, antifolate resistance, arginine biosynthesis, sphingolipid, human cytomegalovirus infection, Kaposi’s sarcoma, small cell lung cancer etc. This evidence concerns the gene EGFR and small cell lung carcinoma.